RECOVERY trial of COVID-19 treatments stops colchicine armMarch 8, 2021COVID-19 UpdatesRheumatologyInfectious DiseasesCardiology
Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung diseaseMarch 5, 2021PulmonologyRheumatologyRare Diseases
COVID-19 vaccination recommended for rheumatology patientsFebruary 24, 2021COVID-19 UpdatesPediatricsRheumatologyVaccines
Pandemic puts patients with psoriatic disease off seeking medical helpFebruary 23, 2021DermatologyRheumatologyCOVID-19 Updates
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)February 5, 2021PediatricsRheumatologyGastroenterologyPulmonology
COVID-19: Another study links colchicine to better resultsFebruary 4, 2021COVID-19 UpdatesInfectious DiseasesRheumatology
Could an osteoporosis drug reduce need for hip revision surgery?January 15, 2021RheumatologyGeriatrics
Joint guidelines favor antibody testing for certain Lyme disease manifestationsDecember 8, 2020Infectious DiseasesPainRheumatologyNeurology
Cognitive Behavioral Therapy Plus Placebo Is Inferior to NSAID Therapy for Arthritis PainDecember 2, 2020RheumatologyMusculoskeletal DisordersPainMental HealthDrug TherapyGeriatrics
